BRAND: VALGANCICLOVIR ROWEX
ACTIVE INGREDIENT: Valganciclovir
STRENGTH & PACK SIZE & GMS CODES:
450 mg Film-coated Tablets x 60
- Valganciclovir Rowex is indicated for the induction and maintenance treatment of cytomegalovirus (CMV) retinitis in adult patients with acquired immunodeficiency syndrome (AIDS).
- Valganciclovir Rowex is indicated for the prevention of CMV disease in CMV-negative adults and children (aged from birth to 18 years) who have received a solid organ transplant from a CMV-positive donor.